Welcome to our dedicated page for Kaya Hldgs news (Ticker: KAYS), a resource for investors and traders seeking the latest updates and insights on Kaya Hldgs stock.
Kaya Holdings Inc (KAYS) operates across hospitality, aviation, and emerging mind care sectors including medical cannabis and psilocybin therapy. This page aggregates all official announcements and developments for this diversified conglomerate.
Investors and industry observers will find curated press releases covering financial results, strategic partnerships, regulatory milestones, and operational expansions. Content spans KAYS' core business units: traditional infrastructure sectors, cannabis license updates, and innovations through The Sacred Mushroom™ treatment centers.
Key updates include earnings disclosures, acquisition activity, product launches in cannabis markets, and progress in psychedelic-assisted therapy research. All materials maintain compliance with financial disclosure standards while providing actionable insights into cross-sector performance.
Bookmark this page for streamlined access to KAYS' evolving business landscape. Check regularly for updates reflecting the company's unique integration of established industries with progressive health initiatives.
Kaya Holdings, Inc. (KAYS) has finalized a settlement with Sunstone Capital Partners concerning the delivery of Oregon Cannabis Production and Processing Licenses. As part of the deal, Bruce Burwick returned 1,006,671 shares to KAYS and received $160,000 from the sale of the facility's grow license. KAYS plans to use the proceeds from selling the property to advance projects in the U.S., Israel, and Greece, aiming to enhance its balance sheet and increase revenues. The company also launched a new logo and website to reflect its global expansion efforts.
Kaya Holdings, Inc. (KAYS) announced participation in the webinar "Cannabis Investment: How Greece is Embracing the Opportunity and Leading the EU Market." CEO Craig Frank highlighted the company's commitment to developing a cannabis cultivation facility in Greece, which, upon obtaining financing and licensing, aims to produce over 85 tonnes of medical-grade cannabis annually for export. The company also operates multiple subsidiaries focused on cannabis retail and product development in the U.S. and plans to expand into international markets, including Greece and Israel.
Kaya Holdings, Inc. (KAYS) announces participation in a May 20, 2021 webinar on cannabis opportunities in Greece, co-hosted by Duane Morris and Greece's Consulate General. The webinar will highlight Greece's potential as a cannabis production hub in the EU. CEO Craig Frank emphasized the company's commitment to developing a cannabis cultivation and processing facility in Greece, projected to produce over 85 tonnes of GMP-certified medical cannabis annually for export, subject to financing and licensing. This initiative represents KAYS's broader international expansion strategy into the cannabis market.
Kaya Holdings, Inc. (KAYS) announced that its Israeli subsidiary, Kaya Shalvah, has received an initial permit from Israel's Ministry of Health for cannabis cultivation and processing. This approval allows KAYS to develop a facility in the Green Negev cannabis complex, crucial for its international expansion strategy aimed at tapping into the growing medical cannabis market in the European Union, projected to exceed $146 billion by 2028. The company anticipates producing approximately 600,000 pounds of GMP-certified cannabis annually, facilitating potential exports.
(OTCQB:KAYS) U.S. Cannabis Company to Leverage First-Mover Advantage in Greece and Israel- Initiating Coverage
Kaya Holdings, Inc. (KAYS) has received a Buy Rating and a Fair Value Estimate of $0.89 from Fundamental Research Corp. The company operates in Oregon and is expanding into Israel and Greece, with projects that require funding for facility buildout. The U.S. cannabis market is expected to grow significantly by 2024, while Europe’s market is projected to reach $146.37B by 2028. KAYS has plans for a $45M raise for its Greek project and aims to expand retail stores into Israel upon legalization.
Kaya Holdings (OTCQB: KAYS) has launched the "Pot 4 a Shot" vaccination appreciation program, offering a 10% discount to customers who present proof of COVID-19 vaccination at its Portland and Salem stores. This initiative aims to support government vaccination efforts. CEO Craig Frank expressed hope that the cannabis industry will rally around this cause. Kaya Holdings operates under three subsidiaries focusing on cannabis retail, cultivation, and international expansion, while continuously seeking growth opportunities in legal markets.
Kaya Holdings, Inc. (KAYS) announced a $4 million capital raise through a Confidential Private Placement Memorandum. The funds will support the launch of Kaya Farms operations in Greece and Israel, aiming to produce 600,000 pounds of GMP-certified medical cannabis annually. The Offering consists of 160 Units priced at $25,000 each, including common stock and warrants for future purchases at specified prices. CEO Craig Frank emphasized that this funding will advance international cultivation efforts. Investments are subject to risks and limited to accredited investors.
Kaya Holdings, Inc. (KAYS) will host a shareholder webinar on September 2, 2020, at 2:00 PM ET to discuss Q2 financial results and advancements in medical cannabis cultivation projects in Greece and Israel. The company aims to produce approximately 600,000 pounds of premium medical-grade cannabis annually for export. CEO Craig Frank highlights the two-year strategic plan for international expansion as a means to leverage KAYS's experience in the U.S. cannabis market. The event will feature live discussions with company executives and updates from operations in various locations.
KAYA Holdings (KAYS) will hold an Online Shareholder Business Update on September 2, 2020, at 2:00 PM ET. The session aims to discuss Q-2 financial results and progress in medical cannabis projects in Greece and Israel. Key operations include the potential for 600,000 pounds of GMP certified cannabis annually for export. The update will feature discussions with management and insights into international cannabis cultivation ventures.
Kaya Holdings, Inc. (KAYS) has announced the appointment of Calliope Zogopoulou as the CEO of its Cannamo™ brand, focusing on CBD pet products. Zogopoulou brings extensive experience from Ambrosia Pet Food, aiming to launch the brand in Greece and the EU. This leadership change is expected to enhance market entry for Cannamo™. Additionally, KAYS is actively collaborating with Day Three Labs for sourcing and logistics, reinforcing its international strategy for growth.
FAQ
What is the current stock price of Kaya Hldgs (KAYS)?
What is the market cap of Kaya Hldgs (KAYS)?
